United States Pharmacopeia (USP) Quality Standards for Dietary Supplements. Nandu Sarma, PhD, RPh. Director, Dietary Supplements
|
|
- Bertram Walton
- 7 years ago
- Views:
Transcription
1 United States Pharmacopeia (USP) Quality Standards for Dietary Supplements Nandu Sarma, PhD, RPh. Director, Dietary Supplements ACPM webinar, July 17, 2014
2 Objectives Describe the dietary supplement regulations with regard to quality and safety expectations, Discuss the pharmacopeial perspectives on the quality and safety of dietary supplements, Describe the challenge and tools to address adulteration of dietary supplements. 2
3 Outline U S Pharmacopeia Dietary supplement regulations quality and safety Pharmacopeial perspectives on the quality and safety of dietary supplements, Adulteration of dietary supplements Disclosures I am an employee of US Pharmacopeia I do not have any other financial or professional conflict of interest I do use dietary supplements 3
4 Mission
5 USP Organization What We Do: Establish and disseminate public written standards for the quality, purity, identity, strength, and labeling of medicines, dietary supplements and foods Provide physical Reference Standards to support tests and assays in the USP NF, DSC, HMC and FCC Educate producers, practitioners, and others seeking information on quality and USP standards 5
6 USP: The Organization Who We Are Over 440 volunteer convention members Over 850 volunteer scientists Over 850 paid staff Locations in Rockville, MD, USA Hyderabad, India Basel, Switzerland Shanghai, China São Paulo, Brazil
7 Call for Candidates Web Page
8 USP Resources Official Documentary Standards New Publications with Authorized Information Compendial Reference Materials Verification Services 8
9
10
11 USP's Relationship to FDA USP: Private Not-For-Profit Organization Development and Revision of Compendial Standards Establish Public Standards strength, purity, quality, identity, packaging, labeling FDA: Government Agency Enforcement Safety (GRAS, Food Additive reviews, etc.) 11
12 Outline U S Pharmacopeia Dietary supplement regulations quality and safety Pharmacopeial perspectives on the quality and safety of dietary supplements, Adulteration of dietary supplements 12
13 Dietary Supplement Health & Education Act 1994 Dietary supplements defined Labelling expectations New Dietary Ingredients Good Manufacturing Practices Compliance with USP: optional. A dietary supplement is deemed misbranded if it (i) is covered by the specifications of an official compendium; (ii) is represented as conforming to the specifications of an official compendium; and (iii) fails to so conform. [FDCA 403(s); 21 U.S.C. 343(s)] Dietary Supplement Health and Education Act of 1994, Public Law (Oct. 25, 1994).
14 Dietary Supplement cgmps and USP Manufacturers decide their own specifications for identity, quality, strength, composition and absence of contaminants. Manufacturers decide how to qualify their suppliers in order to avoid 100% testing of components (condition to accept certificate of analysis) Manufacturers decide on the quality of Reference Materials to calibrate analytical equipment USP mentioned many times in the Preamble as a guidance (scientifically valid methods, reference materials, specifications for dietary ingredients, water purity, etc.) Not included as requirement (consistency with DSHEA) FDA's dietary supplement CGMPs: standards without standardization, FDLI, 63 (4), 2008
15 Safety standards for DS under DSHEA SEC 402 [21 USC 342] A food shall be deemed to be adulterated (f) (1) If it is a dietary supplement or contains a dietary ingredient that (A) presents a significant or unreasonable risk of illness or injury under (i) conditions of use recommended or suggested in labeling, or (ii) if no conditions of use are suggested or recommended in the labeling, under ordinary conditions of use; (B) is a new dietary ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury; (C) the Secretary declares to pose an imminent hazard to public health or safety, except that the authority to make such declaration shall not be delegated and the Secretary shall promptly after such a declaration initiate a proceeding in accordance with sections 554 and 556 of title 5, United States Code, to affirm or withdraw the declaration; or (D) is or contains a dietary ingredient that renders it adulterated under paragraph (a)(1) under the conditions of use recommended or suggested in the labeling of such dietary supplement. In any proceeding under this subparagraph, the United States shall bear the burden of proof on each element to show that a dietary supplement is adulterated. The court shall decide any issue under this paragraph on a de novo basis.
16 Outline U S Pharmacopeia Dietary supplement regulations quality and safety Pharmacopeial perspectives on the quality and safety of dietary supplements, Adulteration of dietary supplements 16
17 White paper 17
18 USP Dietary Supplement Safety Review
19 USP DS Expert Committee: Active Monitoring Program PubMed alert for all the dietary supplements (with monograph in USP) and their marker compounds FDA MedWatch and National Toxicology Program reports British MHRA, Germany, and European Medicines Agency safety alerts TGA (Australia / New Zealand) bulletin Canadian MedEffect bulletin Mailing lists from DS trade associations USP Admission Criteria and Safety Classification for Dietary Supplements Guideline.
20 Evidence-based review Ko et al., Nutrition Reviews, 72(3), , 2014
21 Dietary Supplements Monograph Development 21
22 What is in a USP Monograph? A list of official and validated tests Their analytical procedures Their acceptance criteria In conjunction they define specifications for Identity Quality (Purity, limit for contaminants, Performance and other requirements) Strength Consistent with cgmps for DS
23 Echinacea angustifolia USP 37
24 Echinacea angustifolia USP 37
25 Echinacea angustifolia
26 Echinacea angustifolia
27 Are Disintegration and Dissolution Needed?
28 Goals of Performance Tests Diagnostic Quality Control tool to identify variations in the manufacturing process Confirm the robustness of manufacturing process Predict availability for absorption 28
29 The Value of Public Standards Conservation of FDA and manufacturer resources Uniform standards allow comparisons between products in clinical trials and market place Under DSHEA, consumers don t know to what standards two seemingly equivalent products are held USP promotes Standards with Standardization Private standards not subject to public review - Miller, Celestino, Giancaspro, Williams, Food and Drug Law Journal, 63 (4), 2008
30 Outline U S Pharmacopeia Dietary supplement regulations quality and safety Pharmacopeial perspectives on the quality and safety of dietary supplements, Adulteration of dietary supplements 30
31 Tainted products marketed as Dietary Supplements Phosphodiesterase type 5 inhibitors (e.g., sildenafil) Weightloss drugs (e.g., sibutramine) Controlled substances (e.g., benzodiazepines and anabolic steroids) Anticoagulants (e.g., warfarin) Anticonvulsants (e.g., phenytoin) HMG-CoA reductase inhibitors (e.g., lovastatin) NSAIDs(e.g., indomethacin) Beta blockers (e.g., propranolol) 31
32 General Chapter <2251> Adulteration of Dietary Supplements with Drugs and Drug Analogs Focus on categories of products marketed for sexual enhancement, weight loss, and sport bodybuilding. To develop screening methods for drugs as adulterants for dietary supplements based on the claimed benefits and similar drug effects of such adulterants. 32
33 USP-PDE5i-001-H USP-PDE5i-001-H Bali Mojo CD3CN Extract 1H NMR JCE-PNA-MVX300 2 USP-027-H USP-027-H USP Standard - Tadalafil 1H NMR in CD3CN JCE-PNA-MVX f1 (ppm)
34 Summary USP is a self-supporting, private, non-profit organization. Regulations require use of scientifically valid methods to assure quality of dietary supplements, but may lead to standards without standardization Public standards help conserve resources for the regulators and manufacturers, and help provide confidence for the consumers Uniform standards allow comparisons between products in clinical trials and market place
35 Abbreviations cgmps: current Good Manufacturing Practices ( DS EC: USP Dietary Supplements Expert Committee ( DSC: Dietary Supplements Compendium ( DSHEA: Dietary Supplements Health Education Act ( FCC: Food Chemical Codex ( GRAS: Generally Recognized as Safe ( HMC: Herbal Medicine Compendium ( MHRA: British Medicines and Healthcare Regulation Agency TGA: Australia Therapeutic Goods Administration USP NF: United States Pharmacopeia National Formulary ( 35
36 Nandu Sarma, PhD, RPh. Director, Dietary Supplements Gabriel Giancaspro, PhD. Vice President, Foods Dietary Supplements and Herbal Medicines
The United States Pharmacopeia
INTERNATIONAL MEETING OF WORLD PHARMACOPOEIAS 29 February to 2 March 2012 The United States Pharmacopeia Angela G. Long, M.S. Senior Vice President, Global Alliances and Organizational Affairs Roger L.
More informationCatalog. Global Education. and Training. Global Expertise Trusted Standards Improved Health
Global Education Catalog 2013 2014 and Training Global Expertise Trusted Standards Improved Health USP s mission is to improve global health through public standards and related programs that help ensure
More informationIntroduction to Drug Naming. Angela G. Long, M.S. Senior Vice President, Global Alliances and Organizational Affairs
Introduction to Drug Naming Angela G. Long, M.S. Senior Vice President, Global Alliances and Organizational Affairs What s in a Name? International Nonproprietary Names (INN) Sponsored by World Health
More information1083.4 SUPPLY CHAIN INTEGRITY AND SECURITY
BRIEFING 1083.4 Supply Chain Integrity and Security. A new series of general informational chapters describing various aspects of the pharmaceutical supply chain replaces Good Distribution Practices Supply
More informationGuidance for Industry Certification Process for Designated Medical Gases
Guidance for Industry Certification Process for Designated Medical Gases DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
More informationA Stability Program for the Distribution of Drug Products
A Stability Program for the Distribution of Drug Products Teresa I. Lucas*, Rafik H. Bishara, and Robert H. Seevers Drug products must be transported in a manner that ensures products will be maintained
More informationUSP CONVENTION MEMBERS BY WORLD REGION
USP CONVENTION MEMBERS BY WORLD REGION April 1, 2015 The 459 organizations listed below are Voting Organizational Members of the U.S. Pharmacopeial Convention (USP). WORLD (8) International Council of
More informationVeterinary Compounding
Veterinary Compounding Veterinarians occasionally use compounded preparations to meet a specific patient s medical need. The purpose of this brochure, created jointly by the Animal Health Institute (AHI),
More informationChapter. History and Traditional Technician Roles
Chapter 1 History and Traditional Technician Roles 1 9781449629823_CH01_001_014.indd 1 2 History and Traditional Technician Roles Case Study for Discussion Would it be helpful if pharmacists and pharmacy
More informationStimuli to the Revision Process
2 STIMULI TO THE REVISION PROCESS of the USPC or the USP Council of Experts Vol. 33(6) [Nov. Dec. 2007] The Application of Uncertainty to USP s Compendial Reference Standards Program: Certified Reference
More informationWHITE PAPER USP S ROLE IN SETTING ENFORCEABLE QUALITY STANDARDS FOR MEDICINES
WHITE PAPER USP S ROLE IN SETTING ENFORCEABLE QUALITY STANDARDS FOR MEDICINES SEPTEMBER 23, 2009 COUNCIL OF THE CONVENTION SECTION ON THE QUALITY OF MANUFACTURED MEDICINES INTRODUCTION For nearly two hundred
More informationComparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE
Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance
More informationThird Party Certification Programs for Dietary Supplements
Third Party Certification Programs for Dietary Supplements A Risk Reduction Step for Athletes. Why third party testing? Independent oversight is important in ensuring quality in any business or industry.
More informationGuidance for Industry Time and Extent Applications for Nonprescription Drug Products
Guidance for Industry Time and Extent Applications for Nonprescription Drug Products U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
More informationImplementing New USP Chapters for Analytical Method Validation
Implementing New USP Chapters for Analytical Method Validation March 2010 Ludwig Huber Fax.: +49 7243 602 501 E-mail: Ludwig_Huber@labcompliance.com Today s Agenda Handling Method Changes vs. Adjustments
More informationUSP Strategic Planning and Initiatives
Prescription/Non-Prescription Stakeholder Forum Meeting #6 for 2010-2015 Tuesday, October 21, 2014 USP Strategic Planning and Initiatives Emily M. Kaine, MD Vice President, Strategy Building from our mission,
More informationPremarket Approval Applications (PMAs), Product Development Protocols (PDPs), and Humanitarian Device Exemptions
FDLI s Introduction to Medical Device Law and Regulation: Understanding How FDA Regulates the Medical Device Industry October 28-29, 2002 The Westin Grand Hotel Washington, D.C. Premarket Approval Applications
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 5 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Jabones Pardo S.A.
More informationQuality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion
Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS Eli Lilly & Co. Principal Consultant - Regulatory PDA/FDA Joint September 20 th, 2011
More informationStep-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry
Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry BY GHULAM A. SHABIR Introduction Methods Validation: Establishing documented evidence that provides a high
More informationGUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS.
GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS October 2004 APVMA PO Box E240 KINGSTON 2604 AUSTRALIA http://www.apvma.gov.au
More informationIN THE UNITED STATES IN 2014,
Topics of Professional Interest Quality Certification Programs for Dietary Supplements IN THE UNITED STATES IN 2014, dietary supplements were a $36.7 billion industry. 1 The public has easy access to dietary
More informationBlood, Plasma, and Cellular Blood Components INTRODUCTION
Blood, Plasma, and Cellular Blood Components INTRODUCTION This chapter of the Guideline provides recommendations to Sponsors of Requests for Revision for new monographs for blood, plasma, and cellular
More informationOMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT
OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (11) 204 3R HANDLING AND USE OF REFERENCE STANDARDS IN THE OMCL NETWORK Full document title and reference Document type Legislative
More informationGuidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation
Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
More informationUSP s mission is to improve global health through public. standards and related programs that help ensure the quality,
2015 Catalog USP s mission is to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. 2 Courses listed as of January
More informationAIS Sports Science/Sports Medicine Best Practice Principles
AIS Sports Science/Sports Medicine Best Practice Principles Introduction For the Australian Sports Commission (ASC) and Australian Institute of Sport (AIS), integrity in sport is paramount. Accordingly,
More informationCase 1:15-cv-23419-XXXX Document 1 Entered on FLSD Docket 09/10/2015 Page 1 of 8
Case 1:15-cv-23419-XXXX Document 1 Entered on FLSD Docket 09/10/2015 Page 1 of 8 IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF FLORIDA UNITED STATES OF AMERICA, ) ) Plaintiff, ) ) v.
More informationFood and Drug Administration, HHS Pt. 212
erowe on DSK2VPTVN1PROD with CFR Food and Drug Administration, HHS Pt. 212 investigation was found not to be necessary and the name of the responsible person making such a determination. [43 FR 45077,
More informationGeneral Chapter <800> Open Microphone Web Meeting
General Chapter Open Microphone Web Meeting NOTICE TO PARTICIPANTS: To minimize background noise, all lines will be muted upon joining the session. During the meeting, you may ask questions or make
More informationGlobal Lab Capabilities Pharma Biotech
Global Lab Capabilities Pharma Biotech NSF Health Sciences global network of laboratories delivers expert solutions to pharmaceutical, biotechnology and medical device companies in the areas of analytical
More informationOpen Microphone Meeting:
Open Microphone Meeting: USP General Chapter Pharmaceutical Compounding Sterile Preparations October 21, 2015 2:00 p.m. to 4:00 p.m. EDT Agenda Welcome Overview of USP s Revision Process Overview
More informationFormulary Management
Formulary Management Formulary management is an integrated patient care process which enables physicians, pharmacists and other health care professionals to work together to promote clinically sound, cost-effective
More informationTriangle Compounding 11/2/15
Triangle Compounding 11/2/15 Department of Health and Human Services Public Health Service Food and Drug Administration Atlanta District 60 Eighth Street NE Atlanta, GA 30309 November 2, 2015 VIA UNITED
More informationGuidance for Industry
Guidance for Industry Contract Manufacturing Arrangements for Drugs: Quality Agreements DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
More informationREPORT FOR INTERNATIONAL COOPERATION ON COSMETIC REGULATION (ICCR)
REPORT FOR INTERNATIONAL COOPERATION ON COSMETIC REGULATION (ICCR) Principles for the handling of traces of impurities and/or contaminants in cosmetic products Report is: 1 [Choose One] Prepared For ICCR
More informationGuidance for Industry
Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
More informationEngineering Nanomedical Systems
BME 695 November 8, 2011 Engineering Nanomedical Systems Lecture 15 GMP and issues of quality control manufacture of nanodelivery systems James F. Leary, Ph.D. SVM Endowed Professor of Nanomedicine Professor
More informationAnalysis of Various Vitamins in Multivitamin Tablets
High Performance Liquid Chromatography Analysis of Various Vitamins in Multivitamin Tablets Effective August 24, 2007, the US Food and Drug Administration (FDA) issued a regulation (21 CFR Part 111) that
More informationSQF Level 2 Proposed Preventive Controls Comparison Modules 2 & 11
http://leavittpartners.com/global-food-solutions Contact: david.acheson@leavittpartners.com April 2013 SQF Level 2 Proposed Preventive Controls Comparison Modules 2 & 11 Introduction SQF Level 2, which
More informationMinnesota Board of Pharmacy. Guidance on the Compounding of Veterinary Products Approved: March 4, 2015
EXECUTIVE SUMMARY Minnesota Board of Pharmacy Guidance on the Compounding of Veterinary Products Approved: March 4, 2015 Board staff has held several meetings with representatives of the Minnesota Veterinary
More informationThe Use of Enzymes in Dietary Supplements USP Enzyme Workshop July 8, 2009
The Use of Enzymes in Dietary Supplements USP Enzyme Workshop July 8, 2009 Nena Dockery Introduction and History of Use Commercial production of enzymes for use as digestive aids has an extensive history
More informationUSP Pharmaceutical Ingredient Supplier Qualification Program. Manual for Participants
USP Pharmaceutical Ingredient Supplier Qualification Program Manual for Participants UNITED STATES PHARMACOPEIA Drug Substance Supplier Qualification Program ICE This manual provides information to drug
More informationSPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT
SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT Guideline Title Specifications and Control Tests on the Finished Product Legislative basis Directive 75/318/EEC as amended Date of first adoption
More information2014 Annual Report on Inspections of Establishments
2014 Annual Report on Inspections of Establishments Table of Contents Introduction... 2 Data Collection and Definitions... 3 Section 510(h)(6)(A)(i) Number of Domestic and Foreign Establishments Registered
More informationImporting pharmaceutical products to China
Importing pharmaceutical products to China Imported pharmaceutical products need pre-market approval before entering the Chinese market Imported drugs for human use are required to obtain pre-market approval
More informationExtemporaneously Prepared Early Phase Clinical Trial Materials
Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development
More informationIN THE SENATE OF THE UNITED STATES
II D CONGRESS 1ST SESSION S. 1 To amend title XVIII of the Social Security Act to provide for uniform coverage of anticancer drugs under the medicare program, and for other purposes. IN THE SENATE OF THE
More informationOfficial Journal of the European Union. (Acts whose publication is obligatory)
27.12.2006 L 378/1 I (Acts whose publication is obligatory) REGULATION (EC) No 1901/2006 OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 12 December 2006 on medicinal products for paediatric use and amending
More information2014, That Was The Year That Was Greg Baran, RPh, MA, FMPA Baran Consulting LLC
2014, That Was The Year That Was Greg Baran, RPh, MA, FMPA Baran Consulting LLC Objectives 1. Review the changes to the pharmacy practice act related to sterile compounding. 2. Understand the role of the
More informationProficiency Testing In A Global Analytical Environment Benefits & Challenges. AOAC September 2007
Proficiency Testing In A Global Analytical Environment Benefits & Challenges AOAC September 2007 1 The Coca-Cola Company The Coca-Cola Company is the largest manufacturer, distributor and marketer of nonalcoholic
More informationGuidance for Industry
Guidance for Industry Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
More informationCommentary USP 36-NF 31. Excerpt Related to General Chapter <17> Prescription Container Labeling
Commentary USP 36-NF 31 Excerpt Related to General Chapter Prescription Container Labeling In accordance with USP s Rules and Procedures of the Council of Experts ( Rules ), USP publishes all proposed
More informationPharmacists Pharmacopeia. Official May 1, 2009 August 1, 2009
3 Pharmacists Pharmacopeia Official May 1, 2009 August 1, 2009 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Pharmacists Pharmacopeia of a monograph on any drug
More informationBachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements
Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements Pharmaceutical Sciences Applied sciences that underlie the practice of pharmacy the development, manufacture,
More informationUniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011
Uniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011 1 Outline : Definition Harmonized general chapter USP 34
More informationMarket withdrawal and suspension of marketing authorisation of medicinal product due to good manufacturing practice noncompliance in India
Market withdrawal and suspension of marketing authorisation of medicinal product due to good manufacturing practice noncompliance in India C-269/13 Acino AG vs. European Commission, LS&R 885 Citeersuggestie:
More informationNatural Health Products Bill and Regulations fact versus fiction
Natural Health Products Bill and Regulations fact versus fiction There is a lot of misunderstanding and misinformation about the Natural Health Products Bill and the associated Regulations. The questions
More informationIACP Comparison of 503A and 503B The Drug Quality and Security Act of 2013
Exempt Sections within the Food, Drug, and Cosmetic Act If a "traditional compounder", defined as a licensed pharmacist or licensed physician, meets ALL conditions within Section 503A, the compounder is
More informationMarketed Unapproved Drugs: FDA to Take Immediate Enforcement Action at Any Time, Without Prior Notice
Marketed Unapproved Drugs: FDA to Take Immediate Enforcement Action at Any Time, Without Prior Notice Kurt R. Karst Hyman, Phelps & McNamara, P.C. 700 Thirteenth Street, N.W., Suite 1200 Washington, D.C.
More informationPharmacy and Therapeutics Committee Policies and Procedures
Pharmacy and Therapeutics Committee Policies and Procedures I. Charter... p 2 II. Formulary Principles... p 3 III. Drug Review Process... p 4 7 A. When are Medications Reviewed B. How Are Medications Reviewed
More informationCleaning Validation in Active pharmaceutical Ingredient manufacturing plants
Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants September 1999 Table of contents 1. Foreword...... 2 2. Objective...... 3 3. Scope........ 4 4. Potential residues... 5 5. Current
More informationRevision of The Dissolution Procedure: Development and Validation 1092
Page 1 of 5 STIMULI TO THE REVISION PROCESS Stimuli articles do not necessarily reflect the policies of the USPC or the USP Council of Experts Revision of The Dissolution Procedure: Development and Validation
More informationU.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 OTC
Guidance for Industry Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act: Questions
More informationGraduate Education in Pharmacy Schools: Pharmacy Administration
Graduate Education in Pharmacy Schools: Pharmacy Administration Developed by: Noel E. Wilkin, R.Ph., Ph.D. Associate Provost Associate Professor, Department Chair: Donna West, RPh, PhD Associate Professor,
More informationMedical Device Reporting. Sharon Kapsch Office of Surveillance and Biometrics Center for Devices & Radiological Health Food & Drug Administration
Medical Device Reporting Sharon Kapsch Office of Surveillance and Biometrics Center for Devices & Radiological Health Food & Drug Administration Session Overview Purpose: To provide information about the
More informationG. Recalls. http://www.fda.gov/safety/recalls/industryguidance/ucm129259.htm.
G. Recalls 1. Background When an FDA-regulated product is defective, potentially harmful, or mislabeled, recalling that product removing it from the market or correcting the problem is often the most effective
More informationGuidance for Industry
Guidance for Industry Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP U.S. Department of Health and Human Services Food and Drug Administration Center for Drug
More informationOne Hundred Tenth Congress of the United States of America
S. 1858 One Hundred Tenth Congress of the United States of America AT THE SECOND SESSION Begun and held at the City of Washington on Thursday, the third day of January, two thousand and eight An Act To
More informationWorking with ICH Quality Guidelines - the Canadian Perspective
Working with ICH Quality Guidelines the Canadian Perspective Krishnan Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences Therapeutic Products Directorate Health Canada December 3, 2008 Outline Introduction
More informationFDA s Final Compliance Policy Guide for Marketed Unapproved Drugs Is Agency Enforcement at a Crossroads, or Stuck in a Traffic Circle
FDA s Final Compliance Policy Guide for Marketed Unapproved Drugs Is Agency Enforcement at a Crossroads, or Stuck in a Traffic Circle Kurt R. Karst Associate Hyman, Phelps & McNamara, P.C. 700 Thirteenth
More informationS. ll IN THE SENATE OF THE UNITED STATES A BILL
TH CONGRESS ST SESSION S. ll To amend the Federal Food, Drug, and Cosmetic Act to require that genetically engineered food and foods that contains genetically engineered ingredients be labeled accordingly.
More informationFinalized by the Codex Alimentarius Commission July 4, 2005 Guidelines for Vitamin and Mineral Food Supplements PREAMBLE
Revised Version - Text of final Codex Vitamin and Mineral Guideline. Offered for Amendment on behalf of Natural Solutions Foundation and Citizens Working Group on Codex Finalized by the Codex Alimentarius
More informationNatural Health Products Directorate - Direction des produits de santé naturels
Site Licensing & Good Manufacturing Practices Requirements for Natural Health Products in Canada Canadian Association of Professional Regulatory Affairs Annual Education Day - June 5, 2012 Raymond W. Tsang,
More informationDrug Imports Exports Compliance
Drug Imports Exports Compliance 1 CDER Office of Compliance Office of Drug Security, Integrity & Recalls Division of Import Operations & Recalls Imports Exports Compliance Branch FDA compliance focal point
More informationBOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 info@bpsweb.org www.bpsweb.
BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 info@bpsweb.org www.bpsweb.org Content Outline for the PEDIATRIC PHARMACY SPECIALTY CERTIFICATION
More informationFOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005)
FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005) Dr.R.MANAVALAN, M.Pharm., Ph.D. Professor and Research Director, Department of Pharmaceutics,
More informationFDA Regulation of Health IT
FDA Regulation of Health IT May 2014 Marian J. Lee Partner King & Spalding +1 (202) 661 7955 mlee@kslaw.com Agenda FDA s Mobile Medical Applications Guidance FDASIA Health IT Report 2 FDA s Mobile Medical
More informationTITLE 42 - Section 11601 - Findings and declarations
TITLE 42 - Section 11601 - Findings and declarations CHAPTER 121 INTERNATIONAL CHILD ABDUCTION REMEDIES Sec. 11601. Findings and declarations. 11602. Definitions. 11603. Judicial remedies. 11604. Provisional
More informationBill Mixon, RPh, MS Senior Associate Gates Healthcare Associates
Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates 14 pharmacists and 1 epidemiologist make up the committee USP staff FDA and CDC representatives have input but do not vote Call for Candidates
More informationIndustry Perspective on Managing Risks in a Global Market
Industry Perspective on Managing Risks in a Global Market Institute of Medicine Managing Food Safety Practices from Farm to Table September 9, 2008 Robert E. Brackett, Ph.D. Senior Vice President and Chief
More informationPharmaceutical Quality Systems: US Perspective
Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical
More informationThe purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.
Supplier Quality Standard 1.0 Purpose The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers. These expectations
More informationDietary Supplements: What Is Safe?
Dietary Supplements: What Is Safe? What you need to know first about dietary supplements Dietary supplements include things like vitamins, minerals, herbs, or products made from plants. They can also be
More informationCheck List. Telehealth Credentialing and Privileging Sec. 482.12. Conditions of Participation Governing Body
Check List Telehealth Credentialing and Privileging Sec. 482.12. Conditions of Participation Governing Body The Centers for Medicare and Medicaid Services (CMS) final rule on credentialing and privileging
More informationInterplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation
Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation Leslie M. Tector Quarles & Brady LLP September 30, 2014 Objectives Which federal
More informationREGULATIONS FOR THE PHILOSOPHIAE DOCTOR DEGREE (PHD) AT THE NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU) 1
REGULATIONS FOR THE PHILOSOPHIAE DOCTOR DEGREE (PHD) AT THE NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU) 1 Passed by the Board of NTNU on 23 January 2012 under the provisions of the Act of 1 April
More informationLifecycle Management of Analytical Procedures: Method Development, Procedure Performance Qualification, and Procedure Performance Verification a
STIMULI TO THE REVISION PROCESS Stimuli articles do not necessarily reflect the policies of the USPC or the USP Council of Experts Lifecycle Management of Analytical Procedures: Method Development, Procedure
More informationCTC Technology Readiness Levels
CTC Technology Readiness Levels Readiness: Software Development (Adapted from CECOM s Software Technology Readiness Levels) Level 1: Basic principles observed and reported. Lowest level of software readiness.
More informationPage 191 TITLE 21 FOOD AND DRUGS 355 1
Page 191 TITLE 21 FOOD AND DRUGS 355 1 APPEALS TAKEN PRIOR TO OCTOBER 10, 1962 Section 104(d)(3) of Pub. L. 87 781 made amendments to subsec. (h) of this section inapplicable to any appeal taken prior
More informationRecent Updates on European Requirements and what QPs are expected to do
Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status
More informationAn Overview of the Regulation of Homeopathic Drug Products in the United States
An Overview of the Regulation of Homeopathic Drug Products in the United States and the Role of the Homoeopathic Pharmacopoeia Convention of the United States J.P. Borneman, Ph.D. President, Homoeopathic
More informationA Natural Products Association Presents. SQF Certification. Josh Grauso Technical Sales Director UL Registrar
A Natural Products Association Presents SQF Certification June 25, 2015 1:00-2:00pm Josh Grauso Technical Sales Director UL Registrar GoToWebinar Housekeeping: Attendee Participation Your Participation
More information1.0 Introduction Page 2. 2.0 Scope Page 2. 3.0 General Principles of Shelf-life Studies Page 3. 4.0 Selection of Batches Page 4
Stability Testing Guideline for Dietary Supplements Final Draft January 2011 Provided by the NSF Stability Testing Working Group Table of Contents 1.0 Introduction Page 2 2.0 Scope Page 2 3.0 General Principles
More informationC 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to
C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services
More informationNutraceutical Medical Research, LLC. By: Latesha Richards, Marketing Coordinator
The Value of Conducting Post-Marketing Clinical Research On Marketing Strategy Development Nutraceutical Medical Research, LLC By: Latesha Richards, Marketing Coordinator Those of us who are marketing
More informationISCT Stem Cell Translation: Strategies, Best Practices, and Regulatory Considerations September 28, 2010 USP Standards for Cell and Tissue Therapies
ISCT Stem Cell Translation: Strategies, Best Practices, and Regulatory Considerations September 28, 2010 USP Standards for Cell and Tissue Therapies Fouad Atouf, Ph.D. Senior Scientific Liaison Biologics
More informationGUIDELINES FOR FOOD IMPORT CONTROL SYSTEMS
GUIDELINES FOR FOOD IMPORT CONTROL SYSTEMS SECTION 1 SCOPE CAC/GL 47-2003 1. This document provides a framework for the development and operation of an import control system to protect consumers and facilitate
More informationTopics for today. Issues: Regulatory Obligations Post-marketing Adverse Event Reporting; MDRs and Safety Reports. Post-marketing Submissions
Issues: Regulatory Obligations Post-marketing Adverse Event Reporting; MDRs and Safety Reports Martha A. Feldman, RAC Drug & Device Development Co., Inc. Topics for today Post-approval requirements for
More informationPHARMACEUTICAL REFERENCE STANDARDS
PHARMACEUTICAL REFERENCE STANDARDS 11 th International Symposium organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe 3-4 September 2012, Strasbourg,
More information